Substance abuse treatment, prevention, and policy

Keyphrases

Publications

volume 19, number 1, 2024

Sameeha Misriya Shroff, Chandrashekhar T Sreeramareddy
Marketing claims, promotional strategies, and product information on Malaysian e-cigarette retailer websites-a content analysis. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Danilo Falzon, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Vicki Craik, Rosalind Gittins, Elizabeth V Aston, Kira Watson, Carole Hunter, Saket Priyadarshi, Tessa Parkes
Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E Mushy, Masunga K Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson, Donaldson F Conserve
Residential and inpatient treatment of substance use disorders in Sub-Saharan Africa: a scoping review. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance abuse treatment, prevention, and policy 19 (1) (2024)
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance abuse treatment, prevention, and policy 19 (1) (2024)
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei, Abdolhakim Ghanbarzehi
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Parissa J Ballard, Taylor J Arnold, Elena M Vidrascu, Guadalupe C Hernandez, Emily Ozer, Mark Wolfson, Rebekah Lassiter, Himani Nayyar, Stephanie S Daniel
Pathways to opioid use and implications for prevention: voices of young adults in recovery. Substance abuse treatment, prevention, and policy 19 (1) (2024)
John A Cunningham, Christina Schell, Hollie Walker, Alexandra Godinho
Patterns of remission from alcohol dependence in the United Kingdom: results from an online panel general population survey. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Frankco Harris
Personal recovery for special populations: a qualitative study exploring the role of special interest meetings within 12-step fellowships. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei, Abdolhakim Ghanbarzehi
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Parissa J Ballard, Taylor J Arnold, Elena M Vidrascu, Guadalupe C Hernandez, Emily Ozer, Mark Wolfson, Rebekah Lassiter, Himani Nayyar, Stephanie S Daniel
Pathways to opioid use and implications for prevention: voices of young adults in recovery. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Frankco Harris
Personal recovery for special populations: a qualitative study exploring the role of special interest meetings within 12-step fellowships. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei, Abdolhakim Ghanbarzehi
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei, Abdolhakim Ghanbarzehi
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Danilo Falzon, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Vicki Craik, Rosalind Gittins, Elizabeth V Aston, Kira Watson, Carole Hunter, Saket Priyadarshi, Tessa Parkes
Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Sameeha Misriya Shroff, Chandrashekhar T Sreeramareddy
Marketing claims, promotional strategies, and product information on Malaysian e-cigarette retailer websites-a content analysis. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Eric W Lundstrom, Zheng Dai, Caroline P Groth, Brian Hendricks, Erin L Winstanley, Marie Abate, Gordon S Smith
Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Eric W Lundstrom, Zheng Dai, Caroline P Groth, Brian Hendricks, Erin L Winstanley, Marie Abate, Gordon S Smith
Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E Mushy, Masunga K Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson, Donaldson F Conserve
Residential and inpatient treatment of substance use disorders in Sub-Saharan Africa: a scoping review. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Frankco Harris
Personal recovery for special populations: a qualitative study exploring the role of special interest meetings within 12-step fellowships. Substance abuse treatment, prevention, and policy 19 (1) (2024)
John A Cunningham, Christina Schell, Hollie Walker, Alexandra Godinho
Patterns of remission from alcohol dependence in the United Kingdom: results from an online panel general population survey. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Claire M Ghetti, Steinar Hjelmbrekke, Katharina Morken, Therese Dahl, Brynjulf Stige
Steering the energy with music: hermeneutic phenomenological study of user perspectives of music and music therapy for co-occurring ADHD and substance use problems. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Sameeha Misriya Shroff, Chandrashekhar T Sreeramareddy
Marketing claims, promotional strategies, and product information on Malaysian e-cigarette retailer websites-a content analysis. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Danilo Falzon, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Vicki Craik, Rosalind Gittins, Elizabeth V Aston, Kira Watson, Carole Hunter, Saket Priyadarshi, Tessa Parkes
Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Megan A O'Grady, Katherine S Elkington, Gail Robson, Ikenna Y Achebe, Arthur Robin Williams, Alwyn T Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S Ramsey, Pat Lincourt, Susan Tross
Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators. Substance abuse treatment, prevention, and policy 19 (1) (2024)
John A Cunningham, Christina Schell, Hollie Walker, Alexandra Godinho
Patterns of remission from alcohol dependence in the United Kingdom: results from an online panel general population survey. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Eric W Lundstrom, Zheng Dai, Caroline P Groth, Brian Hendricks, Erin L Winstanley, Marie Abate, Gordon S Smith
Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Sameeha Misriya Shroff, Chandrashekhar T Sreeramareddy
Marketing claims, promotional strategies, and product information on Malaysian e-cigarette retailer websites-a content analysis. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Eric W Lundstrom, Zheng Dai, Caroline P Groth, Brian Hendricks, Erin L Winstanley, Marie Abate, Gordon S Smith
Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Claire M Ghetti, Steinar Hjelmbrekke, Katharina Morken, Therese Dahl, Brynjulf Stige
Steering the energy with music: hermeneutic phenomenological study of user perspectives of music and music therapy for co-occurring ADHD and substance use problems. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Claire M Ghetti, Steinar Hjelmbrekke, Katharina Morken, Therese Dahl, Brynjulf Stige
Steering the energy with music: hermeneutic phenomenological study of user perspectives of music and music therapy for co-occurring ADHD and substance use problems. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Parissa J Ballard, Taylor J Arnold, Elena M Vidrascu, Guadalupe C Hernandez, Emily Ozer, Mark Wolfson, Rebekah Lassiter, Himani Nayyar, Stephanie S Daniel
Pathways to opioid use and implications for prevention: voices of young adults in recovery. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Claire M Ghetti, Steinar Hjelmbrekke, Katharina Morken, Therese Dahl, Brynjulf Stige
Steering the energy with music: hermeneutic phenomenological study of user perspectives of music and music therapy for co-occurring ADHD and substance use problems. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Parissa J Ballard, Taylor J Arnold, Elena M Vidrascu, Guadalupe C Hernandez, Emily Ozer, Mark Wolfson, Rebekah Lassiter, Himani Nayyar, Stephanie S Daniel
Pathways to opioid use and implications for prevention: voices of young adults in recovery. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Danilo Falzon, Hannah Carver, Wendy Masterton, Bruce Wallace, Harry Sumnall, Fiona Measham, Vicki Craik, Rosalind Gittins, Elizabeth V Aston, Kira Watson, Carole Hunter, Saket Priyadarshi, Tessa Parkes
Planning and implementing community-based drug checking services in Scotland: a qualitative exploration using the consolidated framework for implementation research. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E Mushy, Masunga K Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson, Donaldson F Conserve
Residential and inpatient treatment of substance use disorders in Sub-Saharan Africa: a scoping review. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Megan A O'Grady, Katherine S Elkington, Gail Robson, Ikenna Y Achebe, Arthur Robin Williams, Alwyn T Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S Ramsey, Pat Lincourt, Susan Tross
Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Frankco Harris
Personal recovery for special populations: a qualitative study exploring the role of special interest meetings within 12-step fellowships. Substance abuse treatment, prevention, and policy 19 (1) (2024)
John A Cunningham, Christina Schell, Hollie Walker, Alexandra Godinho
Patterns of remission from alcohol dependence in the United Kingdom: results from an online panel general population survey. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Enam Alhagh Charkhat Gorgich, Mohammad Gol Rigi, Hamed Fanaei, Houman Parsaei, Abdolhakim Ghanbarzehi
Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Margaret M Paschen-Wolff, Avery DeSousa, Emily Allen Paine, Tonda L Hughes, Aimee N C Campbell
Experiences of and recommendations for LGBTQ+-affirming substance use services: an exploratory qualitative descriptive study with LGBTQ+ people who use opioids and other drugs. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Samuel Janson, Lily Nyenga, Haneefa Saleem, Larissa Jennings Mayo-Wilson, Stella E Mushy, Masunga K Iseselo, Jenna van Draanen, Joseph Tucker, Mecca McPherson, Donaldson F Conserve
Residential and inpatient treatment of substance use disorders in Sub-Saharan Africa: a scoping review. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Eric W Lundstrom, Zheng Dai, Caroline P Groth, Brian Hendricks, Erin L Winstanley, Marie Abate, Gordon S Smith
Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study. Substance abuse treatment, prevention, and policy 19 (1) (2024)
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance abuse treatment, prevention, and policy 19 (1) (2024)
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter, Eugenia Oviedo-Joekes
Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance abuse treatment, prevention, and policy 19 (1) (2024)